Journal of Clinical Microbiology, March 1999, p. 600-605, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Typing of Clinical Mycobacterium avium Complex
Strains Cultured during a 2-Year Period in Denmark by Using
IS1245
Jeanett
Bauer,1,*
Åse B.
Andersen,1
Dorthe
Askgaard,2
Sten B.
Giese,3 and
Birger
Larsen4
Department of Mycobacteriology, Statens Serum
Institut,1
Department of Infectious
Medicine, Rigshospitalet,2 and
Veterinary Laboratory,3 Copenhagen, and
Department of Infectious Medicine, Marselisborg Hospital,
Århus,4 Denmark
Received 13 July 1998/Returned for modification 13 October
1998/Accepted 7 December 1998
 |
ABSTRACT |
In the present study restriction fragment length polymorphism
analyses with the recently described insertion sequence
IS1245 as a probe was performed with clinical
Mycobacterium avium complex strains cultured in
Denmark during a 2-year period. The overall aim of the study was to
disclose potential routes of transmission of these microorganisms. As a
first step, the genetic diversity among isolates from AIDS patients and
non-human immunodeficiency virus (HIV)-infected patients was described.
In addition, a number of isolates from nonhuman sources cultured during
the same period were analyzed and compared to the human isolates. A
total of 203 isolates from AIDS patients (n = 90),
non-HIV-infected patients (n = 91), and nonhuman sources
(n = 22) were analyzed. The presence of IS1245
was restricted to Mycobacterium avium subsp.
avium isolates. The majority of human isolates had large
numbers of IS1245 copies, while nonhuman isolates could be
divided into a high-copy-number group and a low-copy-number group.
Groups of identical strains were found to be geographically
widespread, comprising strains from AIDS patients as well as strains
from non-HIV-infected patients. Samples of peat (to be used as
potting soil) and veterinary samples were found to contain viable
M. avium isolates belonging to genotypes also found in humans.
 |
INTRODUCTION |
The incidence of Mycobacterium
avium complex (MAC) infections has increased during the last
decade mainly due to disseminated infections in severely
immunocompromised patients infected with the human immunodeficiency
virus (HIV) (13). MAC infections in humans have been known
for years mainly as pulmonary infections in patients with chronic lung
diseases and as lymph node infections in otherwise healthy children.
However, little is still known about the pathogenesis of the infection.
Apparently, the HIV-infected, immunocompromised individual is an
adequate host for MAC since as many as 40% of HIV-positive patients
develop disseminated MAC infection (11, 23), whereas 5% of
other severely immunocompromised patients develop disseminated MAC
infection (14). However, not all HIV-infected patients
contract MAC infection. The route of infection is believed to be the
respiratory or gastrointestinal tract (5, 6, 15), but the
reservoir of human infection is basically unknown, although several
hypotheses have been brought forward over the years (14, 22,
37). Since MAC can be isolated form environmental sources like
water and soil (37-39) and is capable of causing infection
in animals, i.e., birds and pigs, it is usually postulated that the
source of human infection is either the environment or animals. Yet, a
more precise determination of the sources of infection is still needed,
since detailed knowledge might help in the identification of risk
factors so that prophylactic measures could be taken to avoid infection
in HIV-infected patients. In recent years a number of new techniques
for the subtyping of MAC have been described, i.e., pulsed-field gel
electrophoresis (4, 21, 31), ribotyping (24), PCR
(27), and restriction fragment length polymorphism (RFLP)
analyses based on various insertion sequences (9, 29). In
this study RFLP analysis with IS1245 as a probe was used to
genotype MAC strains from Danish AIDS patients, non-HIV-infected
patients, and animal and environmental sources. The aim of the study
was to determine the genetic diversity of the MAC strains infecting
Danish AIDS patients, to compare them with isolates cultured from
HIV-negative patients, and to explore possible relations between the
genotype and the clinical manifestation or demographics. In addition,
we compared the clinical isolates to a number of isolates cultured from
animals and the environment during the same period in order to study
possible sources of infection.
 |
MATERIALS AND METHODS |
Bacterial strains.
The Department of Mycobacteriology at
Statens Serum Institut functions as a central laboratory for the
diagnosis of mycobacterioses including tuberculosis for all of Denmark,
Greenland, and the Faroe Islands. All human isolates were cultured in
this laboratory. Isolates retrieved from HIV-positive patients with
culture-proven MAC infection from January 1994 through March 1996 were
included in the study. The patients were identified as HIV positive by the Danish AIDS register. This procedure was approved by the Danish Data Protection Agency. MAC isolates retrieved from HIV-negative patients from 1994 and 1995 were also included. The first culture of a
specimen from each patient was selected for RFLP analysis.
We obtained the MAC strains cultured from animals and the environment
by the Danish Veterinary Laboratory (DVL) during 1994 and 1995. This
laboratory cultures a small number of specimens for the detection of
mycobacteria. In most cases the specimens are from animals (pigs and
occasionally from pets or wild animals). The environmental isolates
from DVL were cultured from specimens sent from producers of peat and
bedding material. The MAC strains in these specimens consequently
represent a selected fraction of the MAC strains from animals and environment.
Culture.
Blood and bone marrow specimens were inoculated
directly onto BACTEC 13A broth medium (Becton-Dickinson, Sparks, Md.).
Other specimens (except specimens from sterile sites) were
decontaminated with NaOH and centrifuged. The pellet was resuspended in
1 ml of phosphate-buffered saline. Smears were prepared from a portion of the sediment, and the remaining sediment was inoculated onto one
slant of Middlebrook 7H10 agar and into one vial of BACTEC 12B broth
medium. Stool and urine specimens were inoculated onto solid media
only. Specimens were incubated at 35°C for 8 weeks. Species
identification was performed by DNA-RNA hybridization with Accu-Probe
(GenProbe Inc., San Diego, Calif.).
Serotyping.
Serotyping of the nonhuman strains was performed
as part of a previous study (19) by a tube agglutination
test with 28 antiserum specimens as described by Jørgensen
(17). In cases of cross-reactions, an antibody absorption
test was performed (30). No further examination of
nonagglutinable strains or strains showing spontaneous agglutination was performed.
RFLP analysis.
MAC strains were grown for 3 to 4 weeks in 5 ml of Tween-albumin medium. The cultures were centrifuged, heat killed,
and resuspended in 400 µl of TE (Tris-EDTA) buffer. DNA was extracted
as described previously (35). The only minor modification
was the use of phenol-chloroform-isoamyl alcohol (ratios, 25/24/1)
instead of chloroform-isoamyl alcohol (24/1) for extraction.
Approximately 4 µg of DNA was digested with PvuII and was
separated by electrophoresis in a 0.7% agarose gel. After
electrophoresis, the DNA was blotted onto a nylon membrane (Hybond
N+; Amersham). The membrane was hybridized with a
chemiluminescence-labelled (ECL Direct System; Amersham) 427-bp probe
generated by PCR as described previously (9).
Analysis of RFLP patterns.
The RFLP patterns were compared
with GelCompar software (Applied Maths, Kortrijk, Belgium) and
visually. An internal marker of the molecular mass (a
PvuII-digested supercoiled DNA ladder [Boehringer] mixed
with HaeIII-digested
X174 [Boehringer]) was used
to standardize the patterns as described previously (35).
Patient information.
Personal data (nationality, age, sex,
race, HIV risk group, and zip code) and clinical information (date of
AIDS diagnosis, dates of MAC infection and other infections, symptoms
of MAC disease, and paraclinical data) were obtained from the hospital
records of the HIV-infected patients. Permission to collect data was
obtained by the Scientific Ethical Committees for Copenhagen and
Frederiksberg, Denmark. For all patients microbiological data (type of
specimens, results of microscopy, number of colonies, number of
positive specimens, and drug susceptibility patterns) were obtained
from the computerized patient database in the Department of Mycobacteriology.
Statistical analyses.
For comparison of HIV status, HIV risk
group, sex, nationality, and clinical presentation the chi-square
test was used, and Fisher's exact test was used when appropriate. For
comparison of the CD4 levels, the Student t test was used.
 |
RESULTS |
Bacterial isolates.
Bacterial isolates were obtained
from 90 AIDS patients with MAC infection admitted to Danish
hospitals. These patients represented 92% of all AIDS patients
(n = 98) with culture-proven MAC infection in Denmark
from January 1994 to ultimo March 1996. The number of person-months of
AIDS patients in this period was calculated to be 7,805 (32), making the rate of isolation of MAC from AIDS patients
in Denmark during this period approximately 15% per person-year. Of
the 90 isolates, 85 were identified as M. avium subsp.
avium and 5 were positive with the MAC-specific probe but
negative with the probes specific for Mycobacterium
intracellulare and M. avium (8, 33).
Isolates exhibiting these characteristics are, in the following,
designated MAC positive.
MAC isolates were cultured from 130 HIV-negative patients from January
1994 to January 1996. Of these 130 isolates, 13 were identified as
M. intracellulare and were excluded from the study since our results confirmed the observations made by Guerrero et al.
(9) that IS1245 is not present in M. intracellulare (4 M. intracellulare strains were
analyzed). Of the remaining 117 isolates, 91 (78%) were available for
RFLP analysis. A total of 73 (80%) of the isolates were identified as
M. avium subsp. avium and 18 (20%) were
identified as MAC positive.
During 1994 and 1995, DVL had cultured 25 MAC isolates. DNAs for RFLP
analyses were obtained from 22 isolates. Of these 22 isolates, 21 were
identified as M. avium subsp. avium and 1 was identified as M. intracellulare. Table
1 presents the sources and the serovars
of the isolates from DVL.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Sources of isolates, serovars, and distributions of
low-copy-number and high-copy-number strains for nonhuman
MAC isolates
|
|
HIV-infected patients.
The mean age of the patients
included in the study was 38 years (age range, 21 to 63 years). The
demographic data for the patients are presented in Table
2. The mean time to MAC infection from
the time of diagnosis of HIV infection was 12 months (range, 0 to 90 months). For 34 (38%) of the patients, disseminated MAC infection was
the AIDS-defining diagnosis. The clinical presentations of the
patients with MAC infections were comparable to those described by
others (5, 10, 12). Anemia, fever, and weight loss
were the most frequently observed symptoms (95, 80, and 73%,
respectively). Less frequently observed symptoms were elevated liver
enzyme levels, cough, diarrhea, lymphadenopathy, and abdominal pain.
The average CD4 count at the time of MAC diagnosis was 21 × 106/liter (range, 0 to 258 × 109/liter).
MAC was cultured from blood, bone marrow, and/or liver biopsy specimens
from 84% of the patients. MAC was isolated only from pulmonary
specimens from 10% of the patients and was isolated only from stool
specimens from 6% of the patients.
Non-HIV-infected patients.
Demographic data for the 91 HIV-negative patients are presented in Table 2. Of the 42 isolates from
children with lymph node infections, 39 were identified as
M. avium subsp. avium and 3 were identified as MAC
positive. Of the 47 pulmonary isolates, 33 were identified as
M. avium subsp. avium and 14 were identified as MAC positive. One bone marrow isolate from a patient with leukemia was identified as MAC positive and one isolate from urine was identified as M. avium subsp. avium. Of the
isolates from the 47 patients with pulmonary infections, 16 (34%) were
smear positive, 8 (17%) were smear negative but had more than two
specimens that were positive by culture, and 23 (49%) were smear
negative and had only one or two specimens that were positive by culture.
IS1245 patterns.
Of the 23 MAC isolates, 20 carried no copies of IS1245. The remaining three isolates
carried 10, 6, and 5 copies, respectively. All these isolates were from
non-HIV-infected patients. A closer investigation revealed that the
species identification was uncertain for these isolates and was based
primarily on colony morphology and biochemical tests due to repeatedly
unclear results with
Of the 179 M. avium subsp. avium isolates, 5 (2.8%) carried no copies of IS1245 and were consequently
not typeable by RFLP analysis. Of the remaining 174 isolates, the
majority of the human isolates carried multiple copies, while the
nonhuman strains could be divided into a high-copy-number group (11 to
23 bands) and a low-copy-number group (one isolate with 1 band and 8 isolates with three bands). The nonhuman strains had been serotyped
previously (19). The serotypes in relation to copy
number and source of isolate are shown in Table 1. Figure
1 indicates the number of bands for
isolates from AIDS patients, isolates from non-HIV-infected patients, and nonhuman isolates. Comparison of the 174 typeable M. avium subsp. avium isolates revealed 99 different patterns. Seventy-six patterns were unique, and 23 patterns
among 98 isolates were observed more than once.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Numbers of bands for M. avium isolates
cultured from AIDS patients ( ), non-HIV-infected patients ( ), and
nonhuman sources ( ).
|
|
The isolates in several of the 23 clusters (defined as two or more
strains exhibiting indistinguishable patterns) comprised human as well
as nonhuman isolates. Table 3 presents
the number of isolates in the clusters and the distributions for
isolates from AIDS patients, non-HIV-infected patients, and nonhuman
sources. The clusters were geographically widespread, as shown in Fig. 2. The three most prevalent patterns
observed among isolates from humans exhibited a high degree of
similarity. When compared by GelCompar, approximately two-thirds of the
typeable strains exhibited at least 70% homology. Figure
3 provides examples of the three most
prevalent patterns among human isolates and of the most prevalent pattern observed among nonhuman isolates. This pattern (cluster 15) was
observed for 8 of 14 porcine isolates, 7 of which belonged to serovar
2. The pattern was not observed among isolates from AIDS patients but
was found for isolates from two non-HIV-infected patients with
smear-positive pulmonary disease, in one patient with lymphadenitis,
and in a urine sample. Approximately half of the human isolates
belonged to a cluster (isolates from AIDS patients, 54%; isolates from
patients with pulmonary infection, 53%, patients with lymphadenitis,
49%), and there were no significant differences in the odds ratios
that the isolates from AIDS patients, patients with lymphadenitis, and
patients with pulmonary infections were part of a cluster. The odds
ratio that isolates were part of a cluster was not related to
nationality (i.e., native Danes compared to immigrants). Among the
isolates from the AIDS patients, the CD4 levels and clinical
presentations of the patients were compared for patients infected with
the clustered and the nonclustered groups of isolates. No significant
differences were observed. Isolates from AIDS patients were part of 18 of the 23 clusters. Sixteen of these clusters comprised isolates from
patients treated in different hospitals. In order to assess whether
bacterial load would correlate to certain genotypes, isolates from
patients with pulmonary infections were divided into a group consisting
of those from patients with only one or two specimens that were
positive by culture and a group consisting of isolates from patients
who were smear positive or who had more than two specimens that were positive by culture. The cluster frequency was not influenced by
bacterial load. Two of the most frequent clusters (clusters 3 and 12)
were represented in both groups.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 3.
Examples of the four most frequent IS1245
patterns found among 179 human and nonhuman M. avium
isolates.
|
|
 |
DISCUSSION |
During recent years a number of methods have been used to study
the molecular epidemiology of MAC (4, 9, 21, 24, 27, 29),
especially in order to gain an understanding of the sources of
infections for humans. Seroagglutination with polyclonal sera was
previously used to subgroup MAC species into 28 different serovars. MAC
isolates cultured from AIDS and non-AIDS patients during a 7-year
period in Denmark were serotyped in a previous study (1). No
major differences in the serovars infecting AIDS patients versus those
infecting non-AIDS patients were found in that study (1) or
in a U.S. study (34). As pointed out by Denner et al.
(7) the classical seroagglutination assay should be combined
with assays that use monoclonal antibodies and other methods such as
thin-layer and gas chromatographies for better typing results. We chose
to use RFLP analysis with the recently described insertion sequence
IS1245 to characterize Danish MAC strains. Ninety-two and
78% of the M. avium and MAC-positive strains, respectively, cultured from AIDS patients and non-AIDS patients during
a 2-year period were analyzed. Furthermore, we obtained a number of MAC
isolates cultured from the environment and animals during the same period.
As concluded in previous studies (3, 26, 28),
IS1245 was found to be a useful tool for the differentiation
of M. avium strains, and a considerable degree of
polymorphism among strains was observed. However, the large number of
IS1245 copies in M. avium strains and the
fact that many fragments of apparently identical or similar lengths
complicate the interpretation of the results. A proposal for an
optimized and standardized procedure has been established
(36). This procedure will allow future comparison of results
obtained in different laboratories, as has been done for
Mycobacterium tuberculosis (35), with great benefit.
An important issue for the value of IS1245 as an
epidemiological tool is the stability of this insertion element. Recent
studies have demonstrated that the stability in vivo is good (25,
28). Differences between single colonies of the same isolate, in
most cases of 1 to 2 bands, have been observed by Pestel-Caron and Arbeit (25), and this observation has been confirmed in our laboratory (2). In some but not all isolates we observed
similar differences following several subcultures in liquid media,
while no differences could be observed following subcultures on solid media in the study of Pestel-Caron and Arbeit (25). Thus,
the stability of IS1245 appears to be similar to the
stability of IS6110 (40).
Guerrero et al. (9), who first described IS1245
(9), investigated the host range of the insertion element
and concluded that it was present only in M. avium and
not in M. intracellulare or 16 other species
investigated. Of four M. intracellulare strains analyzed during this study, none were found to contain
IS1245 copies, nor did 20 of 23 MAC-positive strains
investigated. The remaining three strains exhibited unique patterns,
with 5, 6, and 10 bands, respectively. These three isolates might have
been classified incorrectly. The use of IS1245 for strain
differentiation is consequently restricted to the M. avium subsp. avium species. However, even among these
strains, 2.8% were found not to carry any copies. This does imply a
limitation of the technique. The majority of the human M. avium subsp. avium isolates carried a large number of
IS1245 copies, while the isolates from nonhuman sources
divided into a high-copy-number group and a low-copy-number group. The
latter consisted of nine strains, eight of which exhibited the same
three-band pattern, most likely the pattern described previously
(9, 28) and designated the "bird" pattern
(28). Seven of the eight isolates belonged to serovar 2, supporting the observations made by Ritacco et al. (28) that
the bird type constitutes a highly conserved group of M. avium strains. This pattern was observed among four human isolates
from non-HIV-infected patients. In at least three cases, the data
suggest that the isolation of this strain might have been of clinical
relevance, since one patient had lymphadenitis and two patients had
smear-positive cultures of pulmonary specimens. However, it has so far
not been observed among isolates from AIDS patients. In general, the
level of similarity between isolates from HIV-positive and HIV-negative patients and the presence of clusters comprising isolates from patients
from both groups suggest that the two groups of patients are likely to
share the same sources of infection. This is in agreement with previous
studies which have demonstrated a lack of correlation between serotype
and HIV infection status (1, 16).
A recent Danish study describing serotypes, IS901 genotypes,
and expression of a 40-kDa protein in MAC strains cultured during 1993 concluded that strains isolated from animals differed distinctly from
strains isolated from humans (19). This is not fully
consistent with our results, since five of the patterns observed among
the 23 isolates from nonhuman sources were found to be identical to those observed among human isolates. Two of these patterns were exhibited by isolates from peat and three were exhibited by porcine isolates. This suggests either that peat is a common source of infection for humans and animals or that animals and peat are potential
sources of infection for humans. The peat samples were sent to DVL from
producers of peat who wanted to control the growth of MAC before and
after heat treatment of their products. The isolates from these samples
were all cultured before heat treatment, and no growth was observed
after heat treatment. However, these products are treated with heat
only when they are to be used for bedding material in piggerys to avoid
MAC infections in pigs. When used for sale as potting soil the
products are not heat treated (18). The peat products are
sold as potting soil throughout Denmark. The clustered isolates were
found to be widely distributed geographically. This could reflect
the equal distributions of genotypes in the environment in Denmark, but
it might also be explained by a single source of infection, e.g., food
or potting soil for potted plants.
Two studies from other countries have demonstrated that potable water
is the source of infection for humans and animals. In one study potable
water from two hospitals was demonstrated to be the source of MAC
infection for four AIDS patients (37), and another study
suggested that potable water in a biolevel 3 containment facility was
the source of infection for at least six rhesus macaques
(20). In Denmark, AIDS patients are mainly treated at only
four hospital departments, two of which are located in Copenhagen.
Water from three of these hospitals was cultured, but no growth of MAC
was identified (data not shown). Furthermore, we collected water
samples from a large Danish lake whose surface water is used as
drinking water during the summer months (data not shown). None of
these samples exhibited growth of MAC. Furthermore, AIDS patients
whose isolates belonged to the same clusters were generally
treated in different hospitals. In conclusion, we have not been able to
demonstrate water as a possible source of MAC infection.
Human-to-human transmission of MAC strains is generally thought to be
unlikely, and the geographical distributions of similar strains found
in this study support this assumption. Isolates from two HIV-positive,
MAC-infected intravenous drug-abusing patients who lived together
exhibited distinctly different patterns (data not shown).
A question of interest is whether MAC disease is due to recent
infection or reactivation of a latent infection. The answer to this
questions might have implications for the type of prophylaxis chosen
for AIDS patients, e.g., vaccination or chemoprophylaxis. In our study
we found that isolates from several small children, who must have been
infected recently, exhibited the same patterns as isolates from AIDS
patients and elderly patients with lung infections. Furthermore,
approximately half of the foreign-born AIDS patients, who
originated from very different geographical areas, were
infected with strains exhibiting the same patterns as those found among
isolates from Danish patients. These observations support the
assumption that MAC disease is due to recent infection.
The presence of rather large groups of identical strains could be
explained by a higher level of virulence of these strains. However, we
were not able to detect any differences in clinical presentation or
immunological status among AIDS patients infected with clustered
strains and AIDS patients infected with unique strains. Similar
observations were made for non-HIV-infected patients with pulmonary
infections. Isolates from patients believed to have clinically
significant M. avium infection, since they were smear
positive or had at least three specimens that were positive by culture,
did not exhibit the most frequent patterns more often than isolates
from patients with only one or two specimens that were positive by
culture. Thus, our data do not support the assumption of a correlation
between IS1245 genotype and a virulent phenotype.
 |
ACKNOWLEDGMENT |
We thank Else Smith, Department of Epidemiology, Statens Serum
Institut, for help with the data from the AIDS register.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Mycobacteriology, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. Phone: 45 3268 3705. Fax: 45 3268 3871. E-mail:
jba{at}ssi.dk.
 |
REFERENCES |
| 1.
|
Askgaard, D. S.,
S. B. Giese,
S. Thybo,
A. Lerche, and J. Bennedsen.
1994.
Serovars of Mycobacterium avium complex isolated from patients in Denmark.
J. Clin. Microbiol.
32:2880-2882[Abstract/Free Full Text].
|
| 2.
|
Bauer, J., and A. B. Andersen.
1999.
Stability of insertion sequence IS1245, a marker for differentiation of M. avium strains.
J. Clin. Microbiol.
37:442-444[Abstract/Free Full Text].
|
| 3.
|
Bono, M.,
T. Jemmi,
C. Bernasconi,
D. Burki,
A. Telenti, and T. Bodmer.
1995.
Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains.
Appl. Environ. Microbiol.
61:371-373[Abstract].
|
| 4.
|
Burki, D. R.,
C. Bernasconi,
T. Bodmer, and A. Telenti.
1995.
Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis.
Eur. J. Clin. Microbiol. Infect. Dis.
14:212-217[Medline].
|
| 5.
|
Chin, D. P.,
P. C. Hopewell,
D. M. Yajko,
E. Vittinghoff,
C. R. Horsburgh, Jr.,
W. K. Hadley,
E. N. Stone,
P. S. Nassos,
S. M. Ostroff,
M. A. Jacobson, et al.
1994.
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection.
J. Infect. Dis.
169:289-295[Medline].
|
| 6.
|
Damsker, B., and E. J. Bottone.
1985.
Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis.
J. Infect. Dis.
151:179-181[Medline].
|
| 7.
|
Denner, J. C.,
A. Y. Tsang,
D. Chatterjee, and P. J. Brennan.
1992.
Comprehensive approach to identification of serovars of Mycobacterium avium complex.
J. Clin. Microbiol.
30:473-478[Abstract/Free Full Text].
|
| 8.
|
GenProbe Inc.
1992.
AccuProbe Mycobacterium avium complex culture identification test. Package insert.
GenProbe Inc., San Diego, Calif.
|
| 9.
|
Guerrero, C.,
C. Bernasconi,
D. Burki,
T. Bodmer, and A. Telenti.
1995.
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness.
J. Clin. Microbiol.
33:304-307[Abstract].
|
| 10.
|
Havlik, J. A., Jr.,
C. R. Horsburgh, Jr.,
B. Metchock,
P. P. Williams,
S. A. Fann, and S. E. Thompson, 3d.
1992.
Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.
J. Infect. Dis.
165:577-580[Medline].
|
| 11.
|
Havlik, J. A., Jr.,
B. Metchock,
S. E. Thompson III,
K. Barrett,
D. Rimland, and C. R. Horsburgh, Jr.
1993.
A prospective evaluation of Mycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with human immunodeficiency virus infection.
J. Infect. Dis.
168:1045-1048[Medline].
|
| 12.
|
Hawkins, C. C.,
J. W. Gold,
E. Whimbey,
T. E. Kiehn,
P. Brannon,
R. Cammarata,
A. E. Brown, and D. Armstrong.
1986.
Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.
Ann. Intern. Med.
105:184-188.
|
| 13.
|
Horsburgh, C. R., Jr.
1991.
Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.
N. Engl. J. Med.
324:1332-1338[Medline].
|
| 14.
|
Inderlied, C. B.,
C. A. Kemper, and L. E. Bermudez.
1993.
The Mycobacterium avium complex.
Clin. Microbiol. Rev.
6:266-310[Abstract/Free Full Text].
|
| 15.
|
Jacobson, M. A.,
P. C. Hopewell,
D. M. Yajko,
W. K. Hadley,
E. Lazarus,
P. K. Mohanty,
G. W. Modin,
D. W. Feigal,
P. S. Cusick, and M. A. Sande.
1991.
Natural history of disseminated Mycobacterium avium complex infection in AIDS.
J. Infect. Dis.
164:994-998[Medline].
|
| 16.
|
Julander, I.,
S. Hoffner,
B. Petrini, and L. Ostlund.
1996.
Multiple serovars of Mycobacterium avium complex in patients with AIDS.
APMIS
104:318-320[Medline].
|
| 17.
|
Jørgensen, J. B.
1978.
Serological investigations of strains of Mycobacterium avium and Mycobacterium intracellulare isolated from animal and non-animal sources.
Nord. Veterinaermed.
30:155-162.
|
| 18.
| Karh, B. (Pindstrup Mosebrug). 1998. Personal
communication.
|
| 19.
|
Klausen, J.,
S. B. Giese,
K. Fuursted, and P. Ahrens.
1997.
Distribution of serotypes, IS901 and a 40 kDa protein in Mycobacterium avium complex strains isolated from man and animals in Denmark.
APMIS
105:277-282[Medline].
|
| 20.
|
Mansfield, K. G., and A. A. Lackner.
1997.
Simian immunodeficiency virus-inoculated macaques acquire Mycobacterium avium from potable water during AIDS.
J. Infect. Dis.
175:184-187[Medline].
|
| 21.
|
Mazurek, G. H.,
S. Hartman,
Y. Zhang,
B. A. Brown,
J. S. Hector,
D. Murphy, and R. J. Wallace, Jr.
1993.
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool.
J. Clin. Microbiol.
31:390-394[Abstract/Free Full Text].
|
| 22.
|
Meissner, G., and W. Anz.
1977.
Sources of Mycobacterium avium complex infection resulting in human diseases.
Am. Rev. Respir. Dis.
116:1057-1064[Medline].
|
| 23.
|
Nightingale, S. D.,
L. T. Byrd,
P. M. Southern,
J. D. Jockusch,
S. X. Cal, and B. A. Wynne.
1992.
Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.
J. Infect. Dis.
165:1082-1085[Medline].
|
| 24.
|
Peillon, R.,
E. B. Drouet,
S. Bruneau,
G. Panteix,
G. A. Denoyel, and H. P. De Montclos.
1994.
Discrimination of Mycobacterium avium-Mycobacterium intracellulare strains by genomic DNA fingerprinting with a 16S rRNA gene probe.
FEMS Microbiol. Lett.
124:75-79[Medline].
|
| 25.
|
Pestel-Caron, M., and R. D. Arbeit.
1998.
Characterization of IS1245 for strain typing of Mycobacterium avium.
J. Clin. Microbiol.
36:1859-1863[Abstract/Free Full Text].
|
| 26.
|
Picardeau, M.,
A. Varnerot,
T. Lecompte,
F. Brel,
T. May, and V. Vincent.
1997.
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.
J. Clin. Microbiol.
35:2503-2510[Abstract].
|
| 27.
|
Picardeau, M., and V. Vincent.
1996.
Typing of Mycobacterium avium isolates by PCR.
J. Clin. Microbiol.
34:389-392[Abstract].
|
| 28.
|
Ritacco, V.,
K. Kremer,
T. van der Laan,
J. E. M. Pijnenburg,
P. E. de Haas, and D. van Soolingen.
1997.
Use of IS901 and IS1245 in RFLP typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates.
Int. J. Tuberc. Lung Dis.
2:242-251.
|
| 29.
|
Roiz, M. P.,
E. Palenque,
C. Guerrero, and M. J. Garcia.
1995.
Use of restriction fragment length polymorphism as a genetic marker for typing Mycobacterium avium strains.
J. Clin. Microbiol.
33:1389-1391[Abstract].
|
| 30.
|
Schaefer, W. B.
1967.
Type-specificity of atypical mycobacteria in agglutination and antibody-absorption tests.
Am. Rev. Respir. Dis.
96:1165-1168[Medline].
|
| 31.
|
Slutsky, A. M.,
R. D. Arbeit,
T. W. Barber,
J. Rich,
C. F. von Reyn,
W. Pieciak,
M. A. Barlow, and J. N. Maslow.
1994.
Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates.
J. Clin. Microbiol.
32:1773-1778[Abstract/Free Full Text].
|
| 32.
| Smith, E. 1998. Personal communication.
|
| 33.
|
Soini, H.,
E. Eerola, and M. K. Viljanen.
1996.
Genetic diversity among Mycobacterium avium complex AccuProbe-positive isolates.
J. Clin. Microbiol.
34:55-57[Abstract].
|
| 34.
|
Tsang, A. Y.,
J. C. Denner,
P. J. Brennan, and K. McClatchy.
1992.
Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates.
J. Clin. Microbiol.
30:479-484[Abstract/Free Full Text].
|
| 35.
|
van Embden, J. D.,
M. D. Cave,
J. T. Crawford,
J. W. Dale,
K. D. Eisenach,
B. Gicquel,
P. Hermans,
C. Martin,
R. McAdam,
T. M. Shinnick, et al.
1993.
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.
J. Clin. Microbiol.
31:406-409[Abstract/Free Full Text].
|
| 36.
|
van Soolingen, D.,
J. Bauer,
V. Ritacco,
S. Cardoso Lexo,
I. Pavlik,
V. Vincent,
N. Rastogi,
T. Bodmer,
C. Garzelli, and M. J. Garcia.
1998.
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization.
J. Clin. Microbiol.
36:3051-3054[Abstract/Free Full Text].
|
| 37.
|
von Reyn, C. F.,
J. N. Maslow,
T. W. Barber,
J. O. Falkinham, and R. D. Arbeit.
1994.
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS.
Lancet
343:1137-1141[Medline].
|
| 38.
|
von Reyn, C. F.,
R. D. Waddell,
T. Eaton,
R. D. Arbeit,
J. N. Maslow,
T. W. Barber,
R. J. Brindle,
C. F. Gilks,
J. Lumio,
J. Lahdevirta, et al.
1993.
Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya.
J. Clin. Microbiol.
31:3227-3230[Abstract/Free Full Text].
|
| 39.
|
Yajko, D. M.,
D. P. Chin,
P. C. Gonzalez,
P. S. Nassos,
P. C. Hopewell,
A. L. Reingold,
C. R. Horsburgh, Jr.,
M. A. Yakrus,
S. M. Ostroff, and W. K. Hadley.
1995.
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals.
J. Acquired Immune Defic. Syndr. Hum. Retrovirol.
9:176-182[Medline].
|
| 40.
|
Yeh, R. W.,
A. Ponce de Leon,
C. B. Agasino,
J. A. Hahn,
C. L. Daley,
P. C. Hopewell, and P. M. Small.
1998.
Stability of Mycobacterium tuberculosis DNA genotype.
J. Infect. Dis.
177:1107-1111[Medline].
|
Journal of Clinical Microbiology, March 1999, p. 600-605, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.